The Business of Biotech
- Article 1 of 7
- iSight, July 2003
The role of start-up biotechnology companies is becoming ever more important as the big pharma companies look to partners to provide innovation and inspiration.
Page 1 | Page 2 | Page 3 | All 3 Pages
With big pharma companies looking to biotechnology companies to bail them out, either through acquisition, partnering or licensing deals, it is up to the biotechs to use this new-found interest wisely. Then, perhaps, they will become the big pharma companies of tomorrow.
Certainly, says Norris of Coprindm, the smaller companies are forcing the broader biotechnology industry to review its business practices. “It used to be the case that there was enough money out there that companies could be highly inefficient and still make plenty of profit. But because there are smaller, much more efficient companies competing in the industry now, that is no longer possible,” he says. “Small, technology focused companies are driving the industry to become much more efficient.”
Page 1 | Page 2 | Page 3 | All 3 Pages